PODD stock forecast
Our latest prediction for Insulet Corp.'s stock price was made on the Nov. 1, 2019 when the stock price was at 146.48$.
In the short term (2weeks), PODD's stock price should outperform the market by 0.62%. During that period the price should oscillate between -5.58% and +6.17%.
In the medium term (3months), PODD's stock price should outperform the market by 1.81%. During that period the price should oscillate between -13.89% and +17.23%.Get email alerts
Create a solid portfolio with PODD
About Insulet Corp.
Insulet Corp. is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
At the moment the company generates 738M USD in revenues.
On its last earning announcement, the company reported a profit of 0.19$ per share.
The book value per share is 3.04$
Three months stock forecastNov. 1, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|